These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 30522964
1. Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome. Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. J Pharmacol Sci; 2019 Jan; 139(1):46-49. PubMed ID: 30522964 [Abstract] [Full Text] [Related]
2. Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats. Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T. J Gastroenterol Hepatol; 2019 Jan; 34(1):186-193. PubMed ID: 29966173 [Abstract] [Full Text] [Related]
3. Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome. Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Neurogastroenterol Motil; 2020 Jun; 32(6):e13819. PubMed ID: 32056324 [Abstract] [Full Text] [Related]
4. Lovastatin inhibits visceral allodynia and increased colonic permeability induced by lipopolysaccharide or repeated water avoidance stress in rats. Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T. Eur J Pharmacol; 2018 Jan 05; 818():228-234. PubMed ID: 29107672 [Abstract] [Full Text] [Related]
5. Dehydroepiandrosterone sulfate improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome. Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Eur J Pharmacol; 2019 Jun 05; 852():198-206. PubMed ID: 30935894 [Abstract] [Full Text] [Related]
6. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome. Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T. Eur J Pharmacol; 2020 Nov 15; 887():173565. PubMed ID: 32946869 [Abstract] [Full Text] [Related]
7. Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome. Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. Sci Rep; 2019 Dec 20; 9(1):19603. PubMed ID: 31862976 [Abstract] [Full Text] [Related]
8. Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome. Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T. Biomed Pharmacother; 2021 Jul 20; 139():111649. PubMed ID: 33957565 [Abstract] [Full Text] [Related]
9. Tranilast alleviates visceral hypersensitivity and colonic hyperpermeability by suppressing NLRP3 inflammasome activation in irritable bowel syndrome rat models. Nozu T, Arie H, Miyagishi S, Ishioh M, Takakusaki K, Okumura T. Int Immunopharmacol; 2024 May 30; 133():112099. PubMed ID: 38643709 [Abstract] [Full Text] [Related]
10. EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome. Nozu T, Miyagishi S, Nozu R, Ishioh M, Takakusaki K, Okumura T. J Pharmacol Sci; 2021 Jul 30; 146(3):121-124. PubMed ID: 34030794 [Abstract] [Full Text] [Related]
11. Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide. Paragomi P, Rahimian R, Kazemi MH, Gharedaghi MH, Khalifeh-Soltani A, Azary S, Javidan AN, Moradi K, Sakuma S, Dehpour AR. Clin Exp Pharmacol Physiol; 2014 Feb 30; 41(2):118-26. PubMed ID: 24471407 [Abstract] [Full Text] [Related]
12. Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats. Nozu T, Miyagishi S, Kumei S, Nozu R, Takakusaki K, Okumura T. J Gastroenterol Hepatol; 2018 Jan 30; 33(1):232-239. PubMed ID: 28440889 [Abstract] [Full Text] [Related]
13. Oridonin Alleviates Visceral Hyperalgesia in a Rat Model of Postinflammatory Irritable Bowel Syndrome: Role of Colonic Enterochromaffin Cell and Serotonin Availability. Zang KH, Shao YY, Zuo X, Rao Z, Qin HY. J Med Food; 2016 Jun 30; 19(6):586-92. PubMed ID: 27111743 [Abstract] [Full Text] [Related]
14. Grape Seed Extract Eliminates Visceral Allodynia and Colonic Hyperpermeability Induced by Repeated Water Avoidance Stress in Rats. Arie H, Nozu T, Miyagishi S, Ida M, Izumo T, Shibata H. Nutrients; 2019 Nov 04; 11(11):. PubMed ID: 31689935 [Abstract] [Full Text] [Related]
15. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice. Du L, Long Y, Kim JJ, Chen B, Zhu Y, Dai N. Dig Dis Sci; 2019 Mar 04; 64(3):729-739. PubMed ID: 30446929 [Abstract] [Full Text] [Related]
16. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction. Shi HL, Liu CH, Ding LL, Zheng Y, Fei XY, Lu L, Zhou XM, Yuan JY, Xie JQ. World J Gastroenterol; 2015 Apr 28; 21(16):4852-63. PubMed ID: 25944998 [Abstract] [Full Text] [Related]
17. Multispecies probiotic protects gut barrier function in experimental models. Nébot-Vivinus M, Harkat C, Bzioueche H, Cartier C, Plichon-Dainese R, Moussa L, Eutamene H, Pishvaie D, Holowacz S, Seyrig C, Piche T, Theodorou V. World J Gastroenterol; 2014 Jun 14; 20(22):6832-43. PubMed ID: 24944474 [Abstract] [Full Text] [Related]
18. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1. Nozu T, Miyagishi S, Nozu R, Takakusaki K, Okumura T. J Endocrinol; 2018 Nov 01; 239(2):241-252. PubMed ID: 30139928 [Abstract] [Full Text] [Related]
19. Peripheral apelin mediates visceral hypersensitivity and impaired gut barrier in a rat irritable bowel syndrome model. Nozu T, Miyagishi S, Ishioh M, Takakusaki K, Okumura T. Neuropeptides; 2022 Aug 01; 94():102248. PubMed ID: 35526468 [Abstract] [Full Text] [Related]
20. Visceral hypersensitivity in irritable bowel syndrome. Kanazawa M, Hongo M, Fukudo S. J Gastroenterol Hepatol; 2011 Apr 01; 26 Suppl 3():119-21. PubMed ID: 21443723 [Abstract] [Full Text] [Related] Page: [Next] [New Search]